Novel |
BTK |
Bruton tyrosine kinase |
- ER-Phagosome pathway
- MyD88:MAL(TIRAP) cascade initiated on plasma membrane
- Regulation of actin dynamics for phagocytic cup formation
- DAP12 signaling
- FCERI mediated Ca+2 mobilization
- FCERI mediated Ca+2 mobilization
- G alpha (q) signalling events
- G alpha (12/13) signalling events
- MyD88 deficiency (TLR2/4)
- IRAK4 deficiency (TLR2/4)
- RHO GTPases Activate WASPs and WAVEs
- G beta:gamma signalling through BTK
- FCGR3A-mediated phagocytosis
- Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
- Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
|
- Dasatinib
- Inositol 1,3,4,5-Tetrakisphosphate
- XL418
- Ibrutinib
- Acalabrutinib
- Fostamatinib
- Zanubrutinib
- Abivertinib
|
- Agammaglobulinemias, including the following six diseases: X-linked agammaglobulinemia (Bruton's agammaglobulinemia, XLA); IgM heavy chain gene deletions; Ig-alpha defect; Autosomal recessive agammaglobulinaemia; B cell-linker protein (BLNK) deficiency; Leucine-rich repeat-containing 8
- Pituitary Dwarfism (PD); Isolated growth hormone deficiency (IGHD); Short Stature and Pituitary Defects (SSPD); Insulin-like growth factor 1 deficiency (IGFD)
|
Novel |
EXOC5 |
exocyst complex component 5 |
- Translocation of SLC2A4 (GLUT4) to the plasma membrane
- Insulin processing
- VxPx cargo-targeting to cilium
|
|
|
Novel |
SLC35E2A |
solute carrier family 35 member E2A |
|
|
|
Novel |
SSU72 |
SSU72 homolog, RNA polymerase II CTD phosphatase |
- RNA polymerase II transcribes snRNA genes
|
|
|
|
ADRA2A |
adrenoceptor alpha 2A |
- Adrenoceptors
- Adrenaline signalling through Alpha-2 adrenergic receptor
- Adrenaline,noradrenaline inhibits insulin secretion
- G alpha (i) signalling events
- G alpha (z) signalling events
- Surfactant metabolism
|
- Amphetamine
- Tramadol
- Bethanidine
- Ziprasidone
- Cabergoline
- Ropinirole
- Dihydroergotamine
- Amitriptyline
- Clozapine
- Norepinephrine
- Mirtazapine
- Phenylpropanolamine
- Loxapine
- Pramipexole
- Prochlorperazine
- Dipivefrin
- Prazosin
- Chlorpromazine
- Brimonidine
- Haloperidol
- Nortriptyline
- Amoxapine
- Amoxapine
- Lamotrigine
- Clonidine
- Lisuride
- Guanabenz
- Dexmedetomidine
- Trazodone
- Epinephrine
- Phentolamine
- Ergotamine
- Tizanidine
- Apomorphine
- Paroxetine
- Trimipramine
- Epinastine
- Tolazoline
- Fenoldopam
- Pseudoephedrine
- Benzphetamine
- Phenoxybenzamine
- Maprotiline
- Oxymetazoline
- Apraclonidine
- Methyldopa
- Guanfacine
- Ergoloid mesylate
- Promethazine
- Carvedilol
- Nefazodone
- Desipramine
- Escitalopram
- Pergolide
- Bromocriptine
- Quetiapine
- Aripiprazole
- Paliperidone
- Ephedra sinica root
- Mephentermine
- Yohimbine
- Methotrimeprazine
- 4-Methoxyamphetamine
- Dextroamphetamine
- Metamfetamine
- Periciazine
- Zuclopenthixol
- Celiprolol
- Dronedarone
- Lofexidine
- Epicept NP-1
- Mianserin
- Pizotifen
- Asenapine
- Ocaperidone
- Droxidopa
- Flupirtine
- Esmirtazapine
- Xylometazoline
- Levonordefrin
- Naphazoline
- Lurasidone
- Dosulepin
- Etoperidone
- Lorpiprazole
- Cirazoline
- Moxisylyte
- Aranidipine
- Moxonidine
- Pirlindole
- Pipamperone
- Setiptiline
- Racepinephrine
- Dihydroergocornine
- DL-Methylephedrine
- DL-Methylephedrine
- Xylazine
- Indigotindisulfonic acid
- Rilmenidine
- Tiapride
- Dihydroergocristine
- Aripiprazole lauroxil
|
|
|
ADRB2 |
adrenoceptor beta 2 |
- Adrenoceptors
- G alpha (s) signalling events
- Ub-specific processing proteases
- Cargo recognition for clathrin-mediated endocytosis
- Clathrin-mediated endocytosis
- ADORA2B mediated anti-inflammatory cytokines production
|
- Spermine
- Amphetamine
- Betaxolol
- Bethanidine
- Isoetharine
- Cabergoline
- Metoprolol
- Olanzapine
- Atenolol
- Norepinephrine
- Timolol
- Phenylpropanolamine
- Dipivefrin
- Sotalol
- Carteolol
- Nortriptyline
- Propranolol
- Labetalol
- Bisoprolol
- Epinephrine
- Paroxetine
- Trimipramine
- Cryptenamine
- Orciprenaline
- Dobutamine
- Pseudoephedrine
- Alprenolol
- Ritodrine
- Terbutaline
- Bitolterol
- Phenoxybenzamine
- Salmeterol
- Pindolol
- Formoterol
- Salbutamol
- Ergoloid mesylate
- Isoprenaline
- Arbutamine
- Amiodarone
- Carvedilol
- Desipramine
- Propafenone
- Acebutolol
- Nadolol
- Levobunolol
- Metipranolol
- Aripiprazole
- Arformoterol
- Fenoterol
- Pirbuterol
- Bevantolol
- Penbutolol
- Ephedra sinica root
- Ephedrine
- Mephentermine
- Procaterol
- Clenbuterol
- Bambuterol
- Oxprenolol
- Putrescine
- Spermidine
- Celiprolol
- Nebivolol
- Indacaterol
- Bedoradrine
- NCX 950
- Asenapine
- Droxidopa
- Bufuralol
- Protokylol
- (S)-carazolol
- Bopindolol
- Bupranolol
- Befunolol
- Olodaterol
- Vilanterol
- Arotinolol
- Doxofylline
- Racepinephrine
- Dihydroergocornine
- DL-Methylephedrine
- Etafedrine
- Tulobuterol
- Levosalbutamol
- Dihydroergocristine
|
|
|
AFP |
alpha fetoprotein |
- Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
- Post-translational protein phosphorylation
|
|
|
|
ARHGEF18 |
Rho/Rac guanine nucleotide exchange factor 18 |
- NRAGE signals death through JNK
- Rho GTPase cycle
- TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
- TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
- G alpha (12/13) signalling events
|
|
|
|
ARRB1 |
arrestin beta 1 |
- Activated NOTCH1 Transmits Signal to the Nucleus
- G alpha (s) signalling events
- Lysosome Vesicle Biogenesis
- Golgi Associated Vesicle Biogenesis
- Thrombin signalling through proteinase activated receptors (PARs)
- Activation of SMO
- Activation of SMO
- MAP2K and MAPK activation
- Ub-specific processing proteases
- Signaling by moderate kinase activity BRAF mutants
- Signaling by high-kinase activity BRAF mutants
- Signaling by BRAF and RAF fusions
- Paradoxical activation of RAF signaling by kinase inactive BRAF
- Cargo recognition for clathrin-mediated endocytosis
- Clathrin-mediated endocytosis
- Signaling downstream of RAS mutants
- Signaling by RAF1 mutants
|
|
|
|
ATXN10 |
ataxin 10 |
|
|
- Spinocerebellar ataxia (SCA); Machado-Joseph disease (SCA3)
|
|
AVPR2 |
arginine vasopressin receptor 2 |
- Vasopressin-like receptors
- G alpha (s) signalling events
- Vasopressin regulates renal water homeostasis via Aquaporins
- Cargo recognition for clathrin-mediated endocytosis
- Clathrin-mediated endocytosis
- Defective AVP does not bind AVPR2 and causes neurohypophyseal diabetes insipidus (NDI)
- ADORA2B mediated anti-inflammatory cytokines production
|
- Desmopressin
- Vasopressin
- Demeclocycline
- Conivaptan
- Terlipressin
- M0002
- OPC-51803
- Tolvaptan
- Atosiban
- Lypressin
|
- Congenital nephrogenic diabetes insipidus (NDI)
|
|
CACNA1A |
calcium voltage-gated channel subunit alpha1 A |
- Presynaptic depolarization and calcium channel opening
- Regulation of insulin secretion
|
- Ergocalciferol
- Enflurane
- Phenytoin
- Spironolactone
- Magnesium sulfate
- Verapamil
- Levomenthol
- Loperamide
- Bepridil
- Ziconotide
- Dotarizine
- Trimebutine
- Benidipine
- Cilnidipine
- Lacidipine
- Manidipine
- Butamben
- Bioallethrin
- Bioallethrin
- Bioallethrin
|
- Episodic ataxias
- Familial or sporadic hemiplegic migraine
- Spinocerebellar ataxia (SCA); Machado-Joseph disease (SCA3)
|
|
CACNA1B |
calcium voltage-gated channel subunit alpha1 B |
- Presynaptic depolarization and calcium channel opening
|
- Ergocalciferol
- Enflurane
- Amlodipine
- Amlodipine
- Spironolactone
- Verapamil
- Gabapentin
- Levetiracetam
- Seletracetam
- Contulakin-G
- Ziconotide
- Agmatine
- Benidipine
- Cilnidipine
- Butamben
- Bioallethrin
|
|
|
CACNA1C |
calcium voltage-gated channel subunit alpha1 C |
- Adrenaline,noradrenaline inhibits insulin secretion
- NCAM1 interactions
- Regulation of insulin secretion
- Regulation of insulin secretion
- Phase 0 - rapid depolarisation
- Phase 2 - plateau phase
|
- Ergocalciferol
- Enflurane
- Ranolazine
- Phenytoin
- Isradipine
- Topiramate
- Ibutilide
- Diltiazem
- Amlodipine
- Nimodipine
- Nisoldipine
- Spironolactone
- Cinnarizine
- Nicardipine
- Magnesium sulfate
- Verapamil
- Levomenthol
- Ethanol
- Felodipine
- Nitrendipine
- Miconazole
- Nifedipine
- Amiodarone
- Calcium
- Mibefradil
- Dronedarone
- Clevidipine
- Nilvadipine
- Drotaverine
- Trimebutine
- Barnidipine
- Aranidipine
- Benidipine
- Cilnidipine
- Efonidipine
- Lacidipine
- Levamlodipine
- Manidipine
- Butamben
- Isavuconazole
- Propiverine
- Bioallethrin
- Bioallethrin
- Fish oil
|
- Long QT syndrome, including: Romano-Ward syndrome; Jervell and Lange-Nielsen syndrome (JLNS)
- Brugada syndrome (BRS)
|
|
CDC42 |
cell division cycle 42 |
- GPVI-mediated activation cascade
- EGFR downregulation
- Rho GTPase cycle
- Regulation of actin dynamics for phagocytic cup formation
- Regulation of actin dynamics for phagocytic cup formation
- CD28 dependent Vav1 pathway
- EPHB-mediated forward signaling
- EPHB-mediated forward signaling
- DCC mediated attractive signaling
- Inactivation of CDC42 and RAC1
- VEGFA-VEGFR2 Pathway
- Myogenesis
- Myogenesis
- RHO GTPases activate KTN1
- RHO GTPases activate IQGAPs
- RHO GTPases activate PAKs
- RHO GTPases Activate WASPs and WAVEs
- RHO GTPases Activate WASPs and WAVEs
- RHO GTPases Activate Formins
- RHO GTPases Activate Formins
- MAPK6/MAPK4 signaling
- Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
- G beta:gamma signalling through CDC42
- FCGR3A-mediated phagocytosis
- FCGR3A-mediated phagocytosis
- Factors involved in megakaryocyte development and platelet production
|
- Aminophosphonic acid-guanylate ester
- Guanosine-5'-Diphosphate
|
|
|
CTNNA3 |
catenin alpha 3 |
|
|
|
|
CYFIP1 |
cytoplasmic FMR1 interacting protein 1 |
- Regulation of actin dynamics for phagocytic cup formation
- Regulation of actin dynamics for phagocytic cup formation
- VEGFA-VEGFR2 Pathway
- RHO GTPases Activate WASPs and WAVEs
- RHO GTPases Activate WASPs and WAVEs
- Neutrophil degranulation
- FCGR3A-mediated phagocytosis
- FCGR3A-mediated phagocytosis
|
|
|
|
DISC1 |
DISC1 scaffold protein |
|
|
|
|
EPHA7 |
EPH receptor A7 |
- EPH-Ephrin signaling
- EPH-Ephrin signaling
- EPHA-mediated growth cone collapse
- EPHA-mediated growth cone collapse
- EPH-ephrin mediated repulsion of cells
- EPH-ephrin mediated repulsion of cells
|
- 5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide
- Fostamatinib
|
|
|
GNA12 |
G protein subunit alpha 12 |
- G alpha (12/13) signalling events
- Thrombin signalling through proteinase activated receptors (PARs)
- Thrombin signalling through proteinase activated receptors (PARs)
|
|
|